Catalyst Pharma Appoints Richard Daly To Succeed Patrick McEnany As CEO

RTTNews | 680 dias atrás
Catalyst Pharma Appoints Richard Daly To Succeed Patrick McEnany As CEO

(RTTNews) - Biopharmaceutical company Catalyst Pharmaceuticals, Inc. (CPRX) announced Thursday the appointment of Richard Daly as its new Chief Executive Officer, effective January 1, 2024. Daly is a seasoned pharmaceutical executive bringing more than three decades of experience to Catalyst.

In order to facilitate an orderly transition, Patrick McEnany, Founder, Chairman, and CEO, will retire from the CEO position effective December 31, 2023, and at that time will continue in his role as Chairman of the Board.

Prior to his appointment at Catalyst, Daly served as President of CARsgen Therapeutics Corp. since January 2022. Previously, he served as Chief Operating Officer at Beyond Springs Inc. from 2018 to 2022 and as CEO, President, and Chairman of Neuralstem, Inc. Throughout his career, Daly has held prominent leadership positions at leading global pharmaceutical companies, including serving as President of AstraZeneca's U.S. diabetes subsidiary.

Earlier, Daly served at Takeda and TAP Pharmaceuticals, a joint venture established between Takeda and Abbott Laboratories, where he held several senior leadership positions, including the Executive Vice President at Takeda Pharmaceutical North America and the Senior Vice President of Marketing at TAP Pharmaceuticals.

Daly has served on Catalyst's Board of Directors since February 2015 and will continue to serve on the board as the newly appointed CEO.

Marcadores : CPRX
read more
Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma

Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma

Biopharmaceutical company Catalyst Pharmaceuticals, Inc. (CPRX) announced Monday that its collaboration partner, Japan's DyDo Pharma, Inc., reported that it has submitted a New Drug Application (NDA) to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, seeking marketing approval for FIRDAPSE (amifampridine) Tablets 10 mg for the treatment of Lambert Eaton myasthenic syndrome (LEMS) in Japan.
RTTNews | 620 dias atrás
U.S. Consumer Prices Increase In Line With Estimates In July

U.S. Consumer Prices Increase In Line With Estimates In July

Consumer prices in the U.S. increased in line with economist estimates in the month of July, according to closely watched data released by the Commerce Department on Friday. The Commerce Department said its personal consumption expenditures (PCE) price index rose by 0.2 percent in July after climbing 0.3 percent in June. The uptick matched expectations.
RTTNews | 38 minutos atrás
German Unemployment Exceeds 3 Mln

German Unemployment Exceeds 3 Mln

Germany's unemployment exceeded the three million-mark for the first time in a decade in August as the prolonged period of subdued economic activity weighed on the labor market. The number of unemployed persons increased by 46,000 from the previous year to 3.025 million in August. However, unemployment fell by adjusted 9,000 compared to the previous month, while it was forecast to increase by 1
RTTNews | 1h 8min atrás
Pound Slides Against Majors

Pound Slides Against Majors

The British pound weakened against other major currencies in the European session on Friday, weighed down to a large extent by the weakness in the financial sector, amid reports of likely imposition of windfall tax on banks.
RTTNews | 2h 22min atrás
FTSE 100 Weak Again, Looks Headed For Weekly Loss

FTSE 100 Weak Again, Looks Headed For Weekly Loss

U.K. stocks are trading lower on Friday, losing ground for a fourth straight session, weighed down to a large extent by the weakness in the financial sector, amid reports of likely imposition of windfall tax on banks.
RTTNews | 2h 54min atrás